Researchers from University of Chicago Report on Findings in Brain Injury (Intravenous Versus Intraosseous Use of Tranexamic Acid In Patients With Traumatic Brain Injury).

Předmět:	CENTRAL nervous system injuries CENTRAL nervous system diseases CRANIOCEREBRAL injuries BRAIN injuries BRAIN diseases
Zdroj:	Drug Week; 10/18/2024, p2792-2792, 1p
Abstrakt:	A study conducted by researchers from the University of Chicago examined the use of tranexamic acid (TXA) in patients with traumatic brain injury. TXA is an antifibrinolytic drug that has been shown to reduce mortality in head injury cases. The study aimed to determine if the route of administration (intravenous or intraosseous) affected the total drug exposure of TXA. The researchers performed a retrospective analysis of data from the prehospital TXA for traumatic brain injury trial and concluded that further investigation is needed to fully understand the implications of TXA administration via intraosseous access. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu